S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
pixel
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
pixel
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
pixel
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
pixel
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Halozyme TherapeuticsIovance BiotherapeuticsKodiak SciencesAcceleron PharmaBeam Therapeutics
SymbolNASDAQ:HALONASDAQ:IOVANASDAQ:KODNASDAQ:XLRNNASDAQ:BEAM
Price Information
Current Price$46.47$39.47$134.79$140.15$95.58
52 Week RangeBuyBuyHoldBuyBuy
MarketRank™
Overall Score1.51.71.31.40.9
Analysis Score1.53.42.12.41.3
Community Score2.73.22.03.01.9
Dividend Score0.00.00.00.00.0
Ownership Score1.71.72.51.70.8
Earnings & Valuation Score1.90.00.00.00.6
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyBuy
Consensus Price Target$42.92$50.10$130.09$139.69$85.33
% Upside from Price Target-7.65% downside26.93% upside-3.49% downside-0.32% downside-10.72% downside
Trade Information
Market Cap$6.29 billion$5.79 billion$6.04 billion$8.44 billion$5.54 billion
Beta1.770.941.420.59N/A
Average Volume1,527,9771,239,679303,404350,2781,090,246
Sales & Book Value
Annual Revenue$195.99 millionN/AN/A$73.99 million$20,000.00
Price / Sales32.07N/AN/A114.12277,019.51
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.63 per share$2.37 per share$9.32 per share$8.47 per shareN/A
Price / Book73.76N/AN/A16.55
Profitability
Net Income$-72,240,000.00$-197,560,000.00$-47,370,000.00$-124,860,000.00$-78,330,000.00
EPS($0.50)($1.59)($1.25)($2.38)($14.05)
Trailing P/E Ratio290.44N/AN/AN/AN/A
Forward P/E Ratio30.37N/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins10.78%N/AN/A-157.84%-529,075.00%
Return on Equity (ROE)24.29%-50.64%-32.32%-31.62%-103.41%
Return on Assets (ROA)4.08%-45.64%-23.86%-28.11%-48.05%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio3.98%N/AN/AN/AN/A
Current Ratio18.49%11.24%16.96%12.02%4.40%
Quick Ratio16.36%11.24%16.96%12.02%4.40%
Ownership Information
Institutional Ownership Percentage98.45%94.56%82.29%79.78%49.79%
Insider Ownership Percentage2.60%9.90%39.30%2.50%0.74%
Miscellaneous
Employees13214862237166
Shares Outstanding135.28 million146.69 million44.80 million60.25 million57.97 million
Next Earnings Date5/10/2021 (Estimated)5/4/2021 (Estimated)3/15/2021 (Estimated)5/10/2021 (Estimated)3/29/2021 (Estimated)
OptionableOptionableOptionableOptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.